Recent Updates
Recently added Catalysts
SMTI Positive Sentiment

Adjuvant Hydrolyzed Collagen Powder in High-risk Patients With Large Soft Tissue Defects Undergoing Orthoplastic Limb Preservation Surgery

Friday, February 13, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses a presentation by Dr. Christopher Bibbo on the use of adjuvant hydrolyzed collagen powder in high-risk patients undergoing orthoplastic limb preservation surgery. The treatment aims to address large soft tissue defects, potentially enhancing surgical outcomes. The content emphasizes the importance of consulting healthcare professionals regarding treatment options.
Price reaction · baseline $19.425 (2026-02-12 close) · hit pre-market · 7 other SMTI headline(s) in the window, move may be shared
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • The presentation highlights innovative treatment options for high-risk patients.
  • Adjuvant hydrolyzed collagen powder may improve outcomes in limb preservation surgeries.

Full Press Release Details

• Last Updated on February 20, 2026
Presenter: Dr. Christopher Bibbo
Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute for manufacturer instructions nor create new product claims. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Please refer to our Terms of Use .

Related Posts

• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• About Sanara
• Board of Directors
• Surgical Products
• Code of Conduct
• Stock Quote
• Press Releases
• SEC Filings
© 2026 All Rights Reserved. Sanara MedTech Inc.

Frequently Asked Questions

What is the focus of Dr. Bibbo's presentation?

Dr. Bibbo's presentation focuses on using adjuvant hydrolyzed collagen powder in high-risk patients undergoing limb preservation surgery.

Who are the intended patients for this treatment?

The treatment is intended for high-risk patients with large soft tissue defects.

What type of surgery is discussed in the article?

The article discusses orthoplastic limb preservation surgery.

What should patients do before considering treatment?

Patients should consult their healthcare provider for professional medical advice.

ShareAdd on Google
Tags: SMTI Viatris Investor Conferences Healthcare Sanara MedTech orthoplastic surgery limb preservation collagen powder soft tissue defects
Last updated: Feb 13, 2026

Biotech snapshot

Cash runway
$29M liquidity · $0M/mo burn
Low dilution risk